| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2018 | 368 | 0.88 | Why? |
| Genetic Diseases, X-Linked | 2 | 2021 | 237 | 0.75 | Why? |
| Genetic Predisposition to Disease | 10 | 2021 | 4027 | 0.67 | Why? |
| Quantitative Trait Loci | 2 | 2017 | 340 | 0.64 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.58 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.55 | Why? |
| Interferon Type I | 7 | 2021 | 2789 | 0.54 | Why? |
| Autoantibodies | 6 | 2021 | 2094 | 0.43 | Why? |
| Leprosy | 2 | 2017 | 142 | 0.42 | Why? |
| Genetic Association Studies | 3 | 2018 | 559 | 0.42 | Why? |
| Interferon-gamma | 3 | 2018 | 2711 | 0.37 | Why? |
| Lymphotoxin-alpha | 1 | 2007 | 15 | 0.35 | Why? |
| Genetic Diseases, Inborn | 2 | 2021 | 190 | 0.35 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.34 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.31 | Why? |
| Pedigree | 8 | 2021 | 502 | 0.31 | Why? |
| Polyendocrinopathies, Autoimmune | 2 | 2021 | 129 | 0.29 | Why? |
| Penetrance | 3 | 2021 | 121 | 0.29 | Why? |
| Loss of Function Mutation | 3 | 2020 | 244 | 0.26 | Why? |
| Polymorphism, Single Nucleotide | 5 | 2018 | 3607 | 0.25 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.24 | Why? |
| Founder Effect | 3 | 2018 | 92 | 0.24 | Why? |
| Receptor, Interferon alpha-beta | 2 | 2021 | 610 | 0.23 | Why? |
| Phenotype | 6 | 2018 | 4037 | 0.22 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Exons | 2 | 2018 | 158 | 0.22 | Why? |
| Mycobacterium Infections | 2 | 2018 | 72 | 0.22 | Why? |
| Interleukins | 3 | 2017 | 762 | 0.22 | Why? |
| Immune System Diseases | 2 | 2021 | 410 | 0.20 | Why? |
| Mutation | 7 | 2018 | 12376 | 0.20 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 203 | 0.20 | Why? |
| Interleukin-12 Subunit p40 | 2 | 2018 | 26 | 0.20 | Why? |
| 17-Hydroxysteroid Dehydrogenases | 1 | 2018 | 3 | 0.20 | Why? |
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2018 | 5 | 0.19 | Why? |
| Receptors, Laminin | 1 | 2018 | 6 | 0.19 | Why? |
| Yellow fever virus | 1 | 2021 | 205 | 0.19 | Why? |
| Yellow Fever Vaccine | 1 | 2021 | 198 | 0.19 | Why? |
| HLA-D Antigens | 1 | 2018 | 28 | 0.19 | Why? |
| Alu Elements | 1 | 2018 | 22 | 0.19 | Why? |
| Job Syndrome | 1 | 2018 | 15 | 0.19 | Why? |
| Chromosomes, Human, Pair 8 | 1 | 2018 | 25 | 0.19 | Why? |
| Buruli Ulcer | 1 | 2018 | 17 | 0.19 | Why? |
| Mycobacterium ulcerans | 1 | 2018 | 15 | 0.19 | Why? |
| Haploinsufficiency | 1 | 2018 | 28 | 0.18 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2021 | 249 | 0.18 | Why? |
| Hepatitis C, Chronic | 2 | 2018 | 973 | 0.18 | Why? |
| Sequence Analysis, Protein | 1 | 2019 | 309 | 0.18 | Why? |
| Tropheryma | 1 | 2018 | 28 | 0.18 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.18 | Why? |
| Alleles | 5 | 2021 | 1557 | 0.18 | Why? |
| Toll-Like Receptor 3 | 2 | 2020 | 391 | 0.18 | Why? |
| Whipple Disease | 1 | 2018 | 38 | 0.18 | Why? |
| Ribosomal Proteins | 1 | 2018 | 94 | 0.18 | Why? |
| RNA Polymerase III | 1 | 2017 | 18 | 0.18 | Why? |
| Mycobacterium tuberculosis | 2 | 2017 | 1164 | 0.18 | Why? |
| RNA Splicing | 1 | 2018 | 119 | 0.17 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.17 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.17 | Why? |
| Interferon Regulatory Factors | 1 | 2018 | 141 | 0.17 | Why? |
| Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 56 | 0.16 | Why? |
| Enterovirus B, Human | 1 | 2017 | 124 | 0.16 | Why? |
| STAT3 Transcription Factor | 1 | 2018 | 268 | 0.16 | Why? |
| Mycobacterium bovis | 1 | 2017 | 125 | 0.16 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.16 | Why? |
| Pharmacogenetics | 1 | 2017 | 222 | 0.15 | Why? |
| Interferon-alpha | 2 | 2021 | 1442 | 0.15 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2017 | 195 | 0.15 | Why? |
| Fibroblasts | 2 | 2017 | 839 | 0.15 | Why? |
| Interferon-Induced Helicase, IFIH1 | 1 | 2017 | 245 | 0.15 | Why? |
| Polyomavirus Infections | 1 | 2017 | 156 | 0.15 | Why? |
| STAT1 Transcription Factor | 1 | 2017 | 313 | 0.14 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.14 | Why? |
| Chickenpox | 1 | 2017 | 194 | 0.13 | Why? |
| Spleen | 1 | 2018 | 877 | 0.13 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Protein Biosynthesis | 1 | 2018 | 653 | 0.13 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.13 | Why? |
| Neutropenia | 1 | 2017 | 388 | 0.13 | Why? |
| Heterozygote | 3 | 2018 | 249 | 0.12 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.12 | Why? |
| Herpes Zoster | 1 | 2017 | 331 | 0.12 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Picornaviridae Infections | 1 | 2017 | 544 | 0.11 | Why? |
| Whole Exome Sequencing | 3 | 2018 | 437 | 0.11 | Why? |
| Protein Kinase Inhibitors | 1 | 2021 | 1585 | 0.11 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.11 | Why? |
| Rhinovirus | 1 | 2017 | 979 | 0.11 | Why? |
| Consanguinity | 3 | 2018 | 50 | 0.11 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.11 | Why? |
| DNA Mutational Analysis | 3 | 2018 | 581 | 0.11 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 6653 | 0.11 | Why? |
| Candidiasis, Chronic Mucocutaneous | 1 | 2010 | 17 | 0.11 | Why? |
| Sequence Analysis, DNA | 1 | 2019 | 2830 | 0.10 | Why? |
| Research Design | 1 | 2007 | 5830 | 0.10 | Why? |
| Viral Tropism | 1 | 2017 | 1329 | 0.10 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.10 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.10 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.09 | Why? |
| Genes, Recessive | 2 | 2018 | 35 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.09 | Why? |
| Child, Preschool | 11 | 2021 | 36283 | 0.09 | Why? |
| Pneumococcal Infections | 1 | 2014 | 562 | 0.09 | Why? |
| Vietnam | 2 | 2017 | 1665 | 0.08 | Why? |
| Immunotherapy | 1 | 2021 | 2421 | 0.08 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.08 | Why? |
| Software | 1 | 2019 | 2501 | 0.08 | Why? |
| Genome-Wide Association Study | 3 | 2021 | 1648 | 0.08 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3633 | 0.08 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.08 | Why? |
| Homozygote | 2 | 2018 | 230 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.08 | Why? |
| Linkage Disequilibrium | 1 | 2007 | 191 | 0.08 | Why? |
| Leukocytes | 3 | 2018 | 1046 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Infant | 9 | 2021 | 30274 | 0.08 | Why? |
| Child | 12 | 2021 | 70012 | 0.07 | Why? |
| Age of Onset | 1 | 2007 | 557 | 0.07 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.07 | Why? |
| Humans | 36 | 2021 | 930598 | 0.07 | Why? |
| Interleukin-17 | 1 | 2010 | 602 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Adolescent | 12 | 2021 | 86841 | 0.07 | Why? |
| Point-of-Care Systems | 1 | 2017 | 2955 | 0.07 | Why? |
| Immunity, Humoral | 1 | 2018 | 4849 | 0.06 | Why? |
| Host-Pathogen Interactions | 3 | 2017 | 11041 | 0.06 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.06 | Why? |
| Male | 23 | 2021 | 367725 | 0.06 | Why? |
| Nedd4 Ubiquitin Protein Ligases | 1 | 2021 | 43 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Endosomal Sorting Complexes Required for Transport | 1 | 2021 | 67 | 0.06 | Why? |
| Interleukin-12 | 1 | 2001 | 156 | 0.05 | Why? |
| Myocarditis | 1 | 2017 | 2731 | 0.05 | Why? |
| Female | 21 | 2021 | 380317 | 0.05 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2020 | 234 | 0.05 | Why? |
| Adult | 14 | 2021 | 244371 | 0.05 | Why? |
| Skin Diseases | 1 | 2017 | 2509 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Ubiquitination | 1 | 2021 | 343 | 0.05 | Why? |
| Lymphocyte Depletion | 1 | 2021 | 293 | 0.05 | Why? |
| Base Sequence | 2 | 2018 | 3581 | 0.05 | Why? |
| Inflammatory Bowel Diseases | 1 | 2017 | 3209 | 0.05 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2017 | 5164 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| INDEL Mutation | 1 | 2019 | 128 | 0.05 | Why? |
| Mice | 4 | 2021 | 21357 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Benin | 1 | 2018 | 115 | 0.05 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.05 | Why? |
| Genetic Linkage | 1 | 2018 | 87 | 0.05 | Why? |
| Zinc Fingers | 1 | 2018 | 109 | 0.05 | Why? |
| Chromosome Mapping | 1 | 2018 | 178 | 0.04 | Why? |
| Sequence Deletion | 2 | 2018 | 674 | 0.04 | Why? |
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 12 | 0.04 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.04 | Why? |
| Nerve Degeneration | 1 | 2017 | 73 | 0.04 | Why? |
| Polyomavirus | 1 | 2017 | 37 | 0.04 | Why? |
| Chromosome Deletion | 1 | 2017 | 62 | 0.04 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.04 | Why? |
| Hair Diseases | 1 | 2017 | 31 | 0.04 | Why? |
| Exome | 1 | 2018 | 207 | 0.04 | Why? |
| Chromosomes, Human, X | 1 | 2017 | 81 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Cell Nucleus | 1 | 2018 | 399 | 0.04 | Why? |
| 5' Untranslated Regions | 1 | 2018 | 375 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Receptors, Interleukin-1 | 1 | 2017 | 161 | 0.04 | Why? |
| Vaccines, Attenuated | 1 | 2021 | 952 | 0.04 | Why? |
| Cameroon | 1 | 2017 | 464 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2018 | 557 | 0.04 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Fetal Growth Retardation | 1 | 2017 | 217 | 0.04 | Why? |
| Cattle | 1 | 2019 | 1336 | 0.03 | Why? |
| Interferons | 2 | 2017 | 2885 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| Animals | 5 | 2021 | 78931 | 0.03 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.03 | Why? |
| Indoles | 1 | 2021 | 1243 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.03 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.03 | Why? |
| India | 2 | 2007 | 11875 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2020 | 7218 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Saudi Arabia | 2 | 2018 | 4423 | 0.03 | Why? |
| Myocytes, Cardiac | 1 | 2017 | 804 | 0.03 | Why? |
| Demography | 1 | 2017 | 1660 | 0.03 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Brazil | 1 | 2007 | 12582 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| RNA, Messenger | 2 | 2018 | 5131 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Blotting, Western | 1 | 2010 | 863 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2018 | 4758 | 0.02 | Why? |
| Mothers | 1 | 2017 | 1624 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.02 | Why? |
| Autoimmunity | 1 | 2010 | 841 | 0.01 | Why? |
| Cell Line, Transformed | 1 | 2001 | 87 | 0.01 | Why? |
| Mutagenesis, Insertional | 1 | 2001 | 92 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Flow Cytometry | 1 | 2010 | 2393 | 0.01 | Why? |
| Internet | 1 | 2019 | 6204 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.01 | Why? |
| Disease Susceptibility | 1 | 2014 | 4002 | 0.01 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Vaccines | 1 | 2018 | 3692 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Herpesvirus 4, Human | 1 | 2001 | 387 | 0.01 | Why? |
| Haplotypes | 1 | 2001 | 853 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| France | 1 | 2014 | 12074 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Polymorphism, Genetic | 1 | 2001 | 1074 | 0.01 | Why? |
| Pakistan | 1 | 2001 | 2302 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Prospective Studies | 1 | 2014 | 43301 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |